secwatch.observer — SEC 8-K summary
======================================

Issuer:     ICU MEDICAL INC/DE (ICUI)
CIK:        0000883984
Form:       8-K
Filed at:   2026-05-07T23:59:59+00:00
Accession:  0000883984-26-000028
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ICU Medical Q1 GAAP net income $30.1M vs loss a year ago; organic revenue up 1%
-------------------------------------------------------------------------------

- GAAP revenue $530.2M, down 12% YoY due to IV Solutions divestiture; non-GAAP organic revenue up 1%.
- GAAP gross margin improved to 39% from 35%; gross profit $206.2M vs $210.1M.
- GAAP diluted EPS $1.20 vs $(0.63) loss; adjusted diluted EPS $1.97 vs $1.72.
- Adjusted EBITDA $98.7M vs $99.4M; company reiterates focus on innovation and operational efficiency.
- Results reflect first full quarter without IV Solutions; management highlights margin expansion and cash flow.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883984/000088398426000028/0000883984-26-000028-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883984/000088398426000028/icui-20260507.htm
  HTML page:      https://secwatch.observer/filing/0000883984-26-000028

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer